Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.

NCT00266708 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Osteodystrophy

Interventions

DRUG: Risedronate
DRUG: Placebo

Sponsor

Montefiore Medical Center